EMAN - eMagin expects to report Q2 revenue growth of 11-14% on strong military demand

• eMagin ( NYSE: EMAN ) said Thursday it expects to report Q2 revenue of $7M-$7.2M, up 11-14% Y/Y, driven by strong military demand and increased revenue contribution from medical customers.
• The revenue growth was partially offset by decreases in contract revenue related to timing of development activities.
• EMAN's backlog of open orders was $14.3M as of Jun. 30, including $12.8M orders that were shippable in 12 months. That compares prior year's backlog of $10.3M.
• "... our display sales increased during Q2, reflecting strong military shipments and increased veterinary and surgical revenues," said EMAN CEO Andrew Sculley.

For further details see: